Feb 28, 2025 · Lorbrena is prescription medicine used to treat a certain type of non-small cell lung cancer that has spread to other parts of the body. Lorbrena is used only if your cancer has a specific genetic marker (an abnormal "ALK" gene). Your doctor will test you for this gene.

Patients taking crizotinib experienced cancer progression at a median of 9 months. More time is needed to find out if patients taking LORBRENA live longer than patients taking crizotinib. *A statistical term. The median is the middle value in a set of measurements.

INDICATION LORBRENA® (lorlatinib) is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.

Central Nervous System (CNS) Effects: CNS effects include seizures, hallucinations and changes in cognitive function, mood (including suicidal ideation), speech, mental status, and sleep. Withhold...

Lorbrena 25 mg tablet. Color: tan Shape: round Imprint: Pfizer 25 LLN. This medicine is a tan, round, film-coated, tablet imprinted with "Pfizer" and "25 LLN".

LORBRENA is available in a 100-mg strength tablet and a 25-mg strength tablet. HOW LORBRENA WORKS LORBRENA was designed to inhibit the ALK protein, including ALK that has become resistant to other ALK inhibitors. Inhibiting the ALK protein can help LORBRENA slow the growth or spread of ALK+ tumors that have spread to other parts of the body.

LORBRENA is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC): that has spread to other parts of your body. Your healthcare provider will perform a test to make sure that LORBRENA is right for you. It is not known if …

LORBRENA ® is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.

Central Nervous System (CNS) Effects: CNS effects include seizures, psychotic effects and changes in cognitive function, mood (including suicidal ideation), speech, mental status, and sleep....

Lorlatinib, sold under the brand name Lorbrena in the United States, Canada, and Japan, and Lorviqua in the European Union, is an anti-cancer medication used for the treatment of non-small cell lung cancer. [4] .